Buzhen Zhao

Practice Areas

Intellectual Property Rights Patent Law

Career

Mr. Zhao joined Hiways law firm in 2018. Before that, he served as an examiner in the Patent Office and Patent Reexamination Board of CNIPA (China National Intellectual Property Administration). He had over eight years of experience in patent examination, re-examination, invalidation and administrative litigation.

Publications

One of the participants of the research group of "Amendment of Patent Application Documents in the Field of Chemical Medicine" CNIPA 2009-2010.

"Screening of Ineffective Reexamination Cases in the Field of Chemistry—About Article 26.3 of the Patent Law". One of the main author of the subject of CNIPA 2010-2011.

"Research on Patent Difficulties and Hot Issues in Chemical Field", one of the authors of the book published and distributed by Intellectual Property Publishing House, in May 2018.

"Battle of IP Rights in China". Editor-in-chief and case writer of the work, released at Hong Kong INTA Annual Meeting in May 2014.

Identification of Technical Problems and Technical Effects in the Judgment of sufficient disclosure, "Intellectual Property News", 2012.

"Lawyer II", Member of the Editorial Board and case reviewer, People's Court Press, 2020.

Languages Spoken

Chinese

English

Experience

- Led the team to win the Asia IP 2024 Award for Best Pharmaceutical, Biotechnology, and Life Sciences Firm in China.

- Assisted a client in securing China’s first-ever market exclusivity period for generic drugs.

- The drug patent linkage case handled was awarded one of the Top 10 Most Valuable Research Cases in China in 2022.

- Three pharmaceutical patent invalidation cases handled were selected as part of the Top 10 Patent Reexamination and Invalidation Cases in China in 2020.

- Successfully helped a client secure China’s first-ever market exclusivity period for generic drugs.